Description

SHELCAL OS (1X15)

Indications

SHELCAL OS is a dietary supplement primarily indicated for the prevention and treatment of calcium and vitamin D deficiencies. It is particularly beneficial for individuals at risk of osteoporosis, including postmenopausal women, the elderly, and those with limited sun exposure. Additionally, SHELCAL OS is recommended for patients recovering from fractures and those undergoing long-term corticosteroid therapy, which may lead to decreased bone density.

Mechanism of Action

The active ingredients in SHELCAL OS include calcium and vitamin D3 (cholecalciferol). Calcium is a vital mineral that plays a crucial role in maintaining bone structure and function. It is essential for the development and maintenance of healthy bones and teeth. Vitamin D3 enhances the intestinal absorption of calcium and phosphate, which are necessary for bone mineralization. Together, these components work synergistically to promote optimal bone health and prevent bone-related disorders.

Pharmacological Properties

SHELCAL OS contains calcium in the form of calcium carbonate, which is a highly bioavailable source of calcium. When ingested, calcium carbonate dissociates in the acidic environment of the stomach, releasing calcium ions that can be absorbed in the intestines. Vitamin D3 is a fat-soluble vitamin that undergoes conversion in the liver and kidneys to its active form, calcitriol, which facilitates the absorption of calcium and phosphate from the gastrointestinal tract. This mechanism helps to maintain appropriate serum calcium levels and supports overall skeletal health.

Contraindications

SHELCAL OS is contraindicated in individuals with a known hypersensitivity to any of its components. It should not be used in patients with hypercalcemia, hypercalciuria, or renal calculi. Additionally, individuals with certain conditions, such as primary hyperparathyroidism or vitamin D toxicity, should avoid using this supplement. It is essential to consult a healthcare provider before starting SHELCAL OS, especially for individuals with pre-existing medical conditions or those taking other medications.

Side Effects

While SHELCAL OS is generally well-tolerated, some individuals may experience mild gastrointestinal side effects, including constipation, bloating, or flatulence. In rare cases, excessive intake of calcium may lead to hypercalcemia, which can manifest as nausea, vomiting, weakness, and confusion. If any severe side effects occur, it is crucial to seek medical attention promptly. Patients should adhere to the recommended dosage to minimize the risk of adverse effects.

Dosage and Administration

The recommended dosage of SHELCAL OS for adults is typically one tablet daily, taken with a meal to enhance absorption. It is essential to follow the dosage instructions provided by a healthcare professional or as indicated on the product label. For specific populations, such as the elderly or those with certain health conditions, a healthcare provider may recommend a different dosage. It is advisable not to exceed the recommended daily allowance unless directed by a healthcare professional.

Interactions

SHELCAL OS may interact with certain medications, including bisphosphonates, thiazide diuretics, and certain anticonvulsants. Bisphosphonates, used for osteoporosis, may have reduced efficacy when taken concurrently with calcium supplements. Thiazide diuretics can increase calcium levels in the body, potentially leading to hypercalcemia when combined with SHELCAL OS. Additionally, some anticonvulsants may affect vitamin D metabolism. Patients should inform their healthcare provider of all medications and supplements they are taking to avoid potential interactions.

Precautions

Before starting SHELCAL OS, it is essential to assess individual health status and risk factors for calcium and vitamin D deficiency. Patients with a history of kidney stones or renal impairment should use this supplement cautiously and under medical supervision. Regular monitoring of serum calcium and vitamin D levels may be necessary for individuals at risk of hypercalcemia. Pregnant or breastfeeding women should consult their healthcare provider before using SHELCAL OS to ensure it is appropriate for their condition.

Clinical Studies

Numerous clinical studies have evaluated the efficacy of calcium and vitamin D supplementation in improving bone health. Research has shown that adequate intake of calcium and vitamin D can significantly reduce the risk of fractures in postmenopausal women and the elderly. A systematic review published in the Journal of Bone and Mineral Research indicated that combined supplementation of calcium and vitamin D leads to improved bone mineral density and a reduced incidence of osteoporosis-related fractures. Another study highlighted the importance of vitamin D in enhancing calcium absorption, further supporting the use of SHELCAL OS in individuals with deficiencies.

Conclusion

SHELCAL OS is a valuable dietary supplement that provides essential calcium and vitamin D to support bone health and prevent deficiencies. Its well-established mechanism of action, pharmacological properties, and clinical efficacy make it an important option for individuals at risk of osteoporosis and related conditions. However, it is crucial to use this supplement responsibly, adhering to recommended dosages and consulting healthcare professionals as needed to ensure safety and effectiveness.